HuGE Literature Finder
|
||
Records 1-8
|
Patatin-like phospholipase 3 (rs738409) gene polymorphism is associated with increased liver enzymes in obese adolescents and metabolic syndrome in all ages.
Alimentary pharmacology & therapeutics 2015 Jul 42 (1): 99-105. Mangge H, Baumgartner B G, Zelzer S, Prüller F, Schnedl W J, Reininghaus E Z, Haybaeck J, Lackner C, Stauber R, Aigner E, Weghuber |
|
Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants.
European journal of internal medicine 2014 Jul 25 (6): 566-70. Del Ben M, Polimeni L, Brancorsini M, Di Costanzo A, D'Erasmo L, Baratta F, Loffredo L, Pastori D, Pignatelli P, Violi F, Arca M, Angelico |
|
PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome.
Alimentary pharmacology & therapeutics 2014 Mar 39 (5): 532-9. Shen J, Wong G L-H, Chan H L-Y, Chan H-Y, Yeung D K-W, Chan R S-M, Chim A M-L, Chan A W-H, Choi P C-L, Woo J, Chu W C-W, Wong V W |
|
Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.
Endocrine journal 2014 61 (7): 683-9. Kitamoto Aya, Kitamoto Takuya, Nakamura Takahiro, Ogawa Yuji, Yoneda Masato, Hyogo Hideyuki, Ochi Hidenori, Mizusawa Seiho, Ueno Takato, Nakao Kazuwa, Sekine Akihiro, Chayama Kazuaki, Nakajima Atsushi, Hotta Kiku |
|
PNPLA3 Polymorphisms and Liver Aminotransferase Levels in a Mexican American Population.
Clinical and investigative medicine. Médecine clinique et experimentale 2012 35 (4): 4. Li Q, Qu HQ, Rentfro AR, Grove ML, Mirza S, Lu Y, Hanis CL, Fallon MB, Boerwinkle E, Fisher-Hoch SP, McCormick JB |
|
The PNPLA3 rs738409 G-Allele Associates with Reduced Fasting Serum Triglyceride and Serum Cholesterol in Danes with Impaired Glucose Regulation.
PloS one 2012 7 (7): 7. Krarup NT, Grarup N, Banasik K, Friedrichsen M, Færch K, Sandholt CH, Jørgensen T, Poulsen P, Witte DR, Vaag A, Sørensen T, Pedersen O, Hansen T |
|
PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.
Hepatology (Baltimore, Md.) 2010 Sep 52 (3): 904-12. Speliotes Elizabeth K, Butler Johannah L, Palmer Cameron D, Voight Benjamin F, , , , Hirschhorn Joel |
|
Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.
Gastroenterology 2009 Sep 137 (3): 865-72. Kotronen Anna, Peltonen Markku, Hakkarainen Antti, Sevastianova Ksenia, Bergholm Robert, Johansson Lina M, Lundbom Nina, Rissanen Aila, Ridderstråle Martin, Groop Leif, Orho-Melander Marju, Yki-Järvinen Hanne |
- Page last reviewed:Jul 30, 2019
- Page last updated:Oct 10, 2019
- Content source: